Biontech

BioNTech SE, a German biotech headquartered in Mainz, develops mRNA‑based immunotherapies for cancer and infectious diseases. Its pipeline features multiple Phase I‑III candidates targeting solid tumors, and it partners with Genentech, Pfizer, Sanofi and others.

Headquarters: Germany (DEU)

Biontech Logo
Company Profile
  • Employees: 6,772
  • HQ: Mainz
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
BNTX Biontech
Cap: 25.1B
EQUITY NMS USD US09075V1026 Active
📈
Home Login